nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—skeletal joint—systemic scleroderma	0.023	0.199	CbGeAlD
Risedronate—FDPS—connective tissue—systemic scleroderma	0.0101	0.087	CbGeAlD
Risedronate—PTGS2—artery—systemic scleroderma	0.00965	0.0835	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—systemic scleroderma	0.0092	0.0796	CbGeAlD
Risedronate—FDPS—skin of body—systemic scleroderma	0.00908	0.0786	CbGeAlD
Risedronate—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00852	0.624	CbGdCrCtD
Risedronate—PTGS2—endothelium—systemic scleroderma	0.00815	0.0705	CbGeAlD
Risedronate—PTGS2—blood vessel—systemic scleroderma	0.00752	0.065	CbGeAlD
Risedronate—FDPS—digestive system—systemic scleroderma	0.00726	0.0628	CbGeAlD
Risedronate—FDPS—tendon—systemic scleroderma	0.00691	0.0598	CbGeAlD
Risedronate—FDPS—lung—systemic scleroderma	0.00606	0.0525	CbGeAlD
Risedronate—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00514	0.376	CbGdCrCtD
Risedronate—PTGS2—connective tissue—systemic scleroderma	0.00385	0.0334	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—systemic scleroderma	0.00353	0.0305	CbGeAlD
Risedronate—PTGS2—skin of body—systemic scleroderma	0.00348	0.0301	CbGeAlD
Risedronate—PTGS2—digestive system—systemic scleroderma	0.00278	0.0241	CbGeAlD
Risedronate—PTGS2—tendon—systemic scleroderma	0.00265	0.0229	CbGeAlD
Risedronate—PTGS2—lung—systemic scleroderma	0.00232	0.0201	CbGeAlD
Risedronate—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.0007	0.000804	CcSEcCtD
Risedronate—Cough—Lisinopril—systemic scleroderma	0.000698	0.000801	CcSEcCtD
Risedronate—Muscular weakness—Prednisone—systemic scleroderma	0.000695	0.000798	CcSEcCtD
Risedronate—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000694	0.000797	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000692	0.000794	CcSEcCtD
Risedronate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00069	0.000792	CcSEcCtD
Risedronate—Insomnia—Leflunomide—systemic scleroderma	0.000687	0.000789	CcSEcCtD
Risedronate—Abdominal distension—Prednisone—systemic scleroderma	0.000686	0.000788	CcSEcCtD
Risedronate—Paraesthesia—Leflunomide—systemic scleroderma	0.000682	0.000783	CcSEcCtD
Risedronate—Arthralgia—Lisinopril—systemic scleroderma	0.000681	0.000781	CcSEcCtD
Risedronate—Chest pain—Lisinopril—systemic scleroderma	0.000681	0.000781	CcSEcCtD
Risedronate—Myalgia—Lisinopril—systemic scleroderma	0.000681	0.000781	CcSEcCtD
Risedronate—Anxiety—Lisinopril—systemic scleroderma	0.000678	0.000779	CcSEcCtD
Risedronate—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000778	CcSEcCtD
Risedronate—Dyspnoea—Leflunomide—systemic scleroderma	0.000677	0.000777	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000676	0.000776	CcSEcCtD
Risedronate—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000673	0.000773	CcSEcCtD
Risedronate—Dyspepsia—Leflunomide—systemic scleroderma	0.000668	0.000767	CcSEcCtD
Risedronate—Vomiting—Mometasone—systemic scleroderma	0.000667	0.000766	CcSEcCtD
Risedronate—Dry mouth—Lisinopril—systemic scleroderma	0.000666	0.000764	CcSEcCtD
Risedronate—Rash—Mometasone—systemic scleroderma	0.000661	0.000759	CcSEcCtD
Risedronate—Asthenia—Captopril—systemic scleroderma	0.000661	0.000759	CcSEcCtD
Risedronate—Dermatitis—Mometasone—systemic scleroderma	0.000661	0.000759	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00066	0.000758	CcSEcCtD
Risedronate—Osteoarthritis—Methotrexate—systemic scleroderma	0.000659	0.000757	CcSEcCtD
Risedronate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000657	0.000755	CcSEcCtD
Risedronate—Headache—Mometasone—systemic scleroderma	0.000657	0.000755	CcSEcCtD
Risedronate—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000655	0.000753	CcSEcCtD
Risedronate—Insomnia—Mycophenolic acid—systemic scleroderma	0.000655	0.000752	CcSEcCtD
Risedronate—Fatigue—Leflunomide—systemic scleroderma	0.000655	0.000752	CcSEcCtD
Risedronate—Pruritus—Captopril—systemic scleroderma	0.000652	0.000748	CcSEcCtD
Risedronate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00065	0.000747	CcSEcCtD
Risedronate—Pain—Leflunomide—systemic scleroderma	0.000649	0.000746	CcSEcCtD
Risedronate—Constipation—Leflunomide—systemic scleroderma	0.000649	0.000746	CcSEcCtD
Risedronate—Infection—Lisinopril—systemic scleroderma	0.000648	0.000744	CcSEcCtD
Risedronate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000647	0.000743	CcSEcCtD
Risedronate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000646	0.000742	CcSEcCtD
Risedronate—Shock—Lisinopril—systemic scleroderma	0.000642	0.000737	CcSEcCtD
Risedronate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00064	0.000735	CcSEcCtD
Risedronate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000638	0.000732	CcSEcCtD
Risedronate—Body temperature increased—Azathioprine—systemic scleroderma	0.000636	0.00073	CcSEcCtD
Risedronate—Abdominal pain—Azathioprine—systemic scleroderma	0.000636	0.00073	CcSEcCtD
Risedronate—Skin disorder—Lisinopril—systemic scleroderma	0.000634	0.000728	CcSEcCtD
Risedronate—Diarrhoea—Captopril—systemic scleroderma	0.00063	0.000724	CcSEcCtD
Risedronate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000629	0.000723	CcSEcCtD
Risedronate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000628	0.000721	CcSEcCtD
Risedronate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000625	0.000718	CcSEcCtD
Risedronate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000624	0.000717	CcSEcCtD
Risedronate—Nausea—Mometasone—systemic scleroderma	0.000623	0.000715	CcSEcCtD
Risedronate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000621	0.000713	CcSEcCtD
Risedronate—Constipation—Mycophenolic acid—systemic scleroderma	0.000619	0.000711	CcSEcCtD
Risedronate—Pain—Mycophenolic acid—systemic scleroderma	0.000619	0.000711	CcSEcCtD
Risedronate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000616	0.000707	CcSEcCtD
Risedronate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000611	0.000702	CcSEcCtD
Risedronate—Dizziness—Captopril—systemic scleroderma	0.000609	0.0007	CcSEcCtD
Risedronate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000608	0.000698	CcSEcCtD
Risedronate—Depression—Prednisone—systemic scleroderma	0.000606	0.000696	CcSEcCtD
Risedronate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000605	0.000694	CcSEcCtD
Risedronate—Urticaria—Leflunomide—systemic scleroderma	0.000603	0.000693	CcSEcCtD
Risedronate—Abdominal pain—Leflunomide—systemic scleroderma	0.0006	0.000689	CcSEcCtD
Risedronate—Body temperature increased—Leflunomide—systemic scleroderma	0.0006	0.000689	CcSEcCtD
Risedronate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000596	0.000685	CcSEcCtD
Risedronate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000596	0.000685	CcSEcCtD
Risedronate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000596	0.000685	CcSEcCtD
Risedronate—Breast disorder—Methotrexate—systemic scleroderma	0.000595	0.000684	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000594	0.000683	CcSEcCtD
Risedronate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000594	0.000682	CcSEcCtD
Risedronate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000592	0.00068	CcSEcCtD
Risedronate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000592	0.00068	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000592	0.00068	CcSEcCtD
Risedronate—Insomnia—Lisinopril—systemic scleroderma	0.00059	0.000678	CcSEcCtD
Risedronate—Paraesthesia—Lisinopril—systemic scleroderma	0.000586	0.000673	CcSEcCtD
Risedronate—Vomiting—Captopril—systemic scleroderma	0.000586	0.000673	CcSEcCtD
Risedronate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00067	CcSEcCtD
Risedronate—Dyspnoea—Lisinopril—systemic scleroderma	0.000582	0.000668	CcSEcCtD
Risedronate—Rash—Captopril—systemic scleroderma	0.000581	0.000667	CcSEcCtD
Risedronate—Dermatitis—Captopril—systemic scleroderma	0.00058	0.000666	CcSEcCtD
Risedronate—Headache—Captopril—systemic scleroderma	0.000577	0.000663	CcSEcCtD
Risedronate—Dyspepsia—Lisinopril—systemic scleroderma	0.000574	0.000659	CcSEcCtD
Risedronate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000573	0.000657	CcSEcCtD
Risedronate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000573	0.000657	CcSEcCtD
Risedronate—Asthma—Methotrexate—systemic scleroderma	0.000569	0.000654	CcSEcCtD
Risedronate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000568	0.000652	CcSEcCtD
Risedronate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000563	0.000647	CcSEcCtD
Risedronate—Fatigue—Lisinopril—systemic scleroderma	0.000562	0.000646	CcSEcCtD
Risedronate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000646	CcSEcCtD
Risedronate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000561	0.000644	CcSEcCtD
Risedronate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000559	0.000642	CcSEcCtD
Risedronate—Constipation—Lisinopril—systemic scleroderma	0.000558	0.000641	CcSEcCtD
Risedronate—Pain—Lisinopril—systemic scleroderma	0.000558	0.000641	CcSEcCtD
Risedronate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000555	0.000638	CcSEcCtD
Risedronate—Diarrhoea—Azathioprine—systemic scleroderma	0.00055	0.000632	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—systemic scleroderma	0.000548	0.000629	CcSEcCtD
Risedronate—Nausea—Captopril—systemic scleroderma	0.000547	0.000628	CcSEcCtD
Risedronate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000546	0.000627	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—systemic scleroderma	0.000545	0.000626	CcSEcCtD
Risedronate—Asthenia—Leflunomide—systemic scleroderma	0.000545	0.000626	CcSEcCtD
Risedronate—Pruritus—Leflunomide—systemic scleroderma	0.000537	0.000617	CcSEcCtD
Risedronate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000536	0.000615	CcSEcCtD
Risedronate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000533	0.000613	CcSEcCtD
Risedronate—Dizziness—Azathioprine—systemic scleroderma	0.000532	0.00061	CcSEcCtD
Risedronate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000529	0.000608	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000521	0.000598	CcSEcCtD
Risedronate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00052	0.000597	CcSEcCtD
Risedronate—Diarrhoea—Leflunomide—systemic scleroderma	0.000519	0.000597	CcSEcCtD
Risedronate—Urticaria—Lisinopril—systemic scleroderma	0.000518	0.000595	CcSEcCtD
Risedronate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000517	0.000594	CcSEcCtD
Risedronate—Abdominal pain—Lisinopril—systemic scleroderma	0.000516	0.000592	CcSEcCtD
Risedronate—Body temperature increased—Lisinopril—systemic scleroderma	0.000516	0.000592	CcSEcCtD
Risedronate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000589	CcSEcCtD
Risedronate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000512	0.000588	CcSEcCtD
Risedronate—Vomiting—Azathioprine—systemic scleroderma	0.000511	0.000587	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—systemic scleroderma	0.000511	0.000586	CcSEcCtD
Risedronate—Eye disorder—Prednisone—systemic scleroderma	0.00051	0.000585	CcSEcCtD
Risedronate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00051	0.000585	CcSEcCtD
Risedronate—Infestation—Methotrexate—systemic scleroderma	0.000508	0.000583	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—systemic scleroderma	0.000508	0.000583	CcSEcCtD
Risedronate—Rash—Azathioprine—systemic scleroderma	0.000507	0.000582	CcSEcCtD
Risedronate—Dermatitis—Azathioprine—systemic scleroderma	0.000506	0.000582	CcSEcCtD
Risedronate—Depression—Methotrexate—systemic scleroderma	0.000506	0.000581	CcSEcCtD
Risedronate—Headache—Azathioprine—systemic scleroderma	0.000504	0.000578	CcSEcCtD
Risedronate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000503	0.000578	CcSEcCtD
Risedronate—Dizziness—Leflunomide—systemic scleroderma	0.000502	0.000577	CcSEcCtD
Risedronate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000496	0.000569	CcSEcCtD
Risedronate—Angiopathy—Prednisone—systemic scleroderma	0.000495	0.000568	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000493	0.000567	CcSEcCtD
Risedronate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000567	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—systemic scleroderma	0.000493	0.000566	CcSEcCtD
Risedronate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000489	0.000561	CcSEcCtD
Risedronate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000489	0.000561	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—systemic scleroderma	0.000487	0.000559	CcSEcCtD
Risedronate—Vomiting—Leflunomide—systemic scleroderma	0.000483	0.000554	CcSEcCtD
Risedronate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000481	0.000552	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00048	0.000551	CcSEcCtD
Risedronate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000479	0.00055	CcSEcCtD
Risedronate—Rash—Leflunomide—systemic scleroderma	0.000479	0.00055	CcSEcCtD
Risedronate—Dermatitis—Leflunomide—systemic scleroderma	0.000478	0.000549	CcSEcCtD
Risedronate—Mental disorder—Prednisone—systemic scleroderma	0.000478	0.000549	CcSEcCtD
Risedronate—Nausea—Azathioprine—systemic scleroderma	0.000478	0.000548	CcSEcCtD
Risedronate—Headache—Leflunomide—systemic scleroderma	0.000476	0.000546	CcSEcCtD
Risedronate—Malnutrition—Prednisone—systemic scleroderma	0.000475	0.000545	CcSEcCtD
Risedronate—Asthenia—Lisinopril—systemic scleroderma	0.000468	0.000537	CcSEcCtD
Risedronate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000537	CcSEcCtD
Risedronate—Pruritus—Lisinopril—systemic scleroderma	0.000462	0.00053	CcSEcCtD
Risedronate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00046	0.000529	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—systemic scleroderma	0.000458	0.000526	CcSEcCtD
Risedronate—Rash—Mycophenolic acid—systemic scleroderma	0.000457	0.000524	CcSEcCtD
Risedronate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000456	0.000524	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—systemic scleroderma	0.000456	0.000523	CcSEcCtD
Risedronate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000521	CcSEcCtD
Risedronate—Headache—Mycophenolic acid—systemic scleroderma	0.000454	0.000521	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—systemic scleroderma	0.000452	0.000519	CcSEcCtD
Risedronate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000519	CcSEcCtD
Risedronate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000519	CcSEcCtD
Risedronate—Nausea—Leflunomide—systemic scleroderma	0.000451	0.000518	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00045	0.000517	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—systemic scleroderma	0.000447	0.000513	CcSEcCtD
Risedronate—Diarrhoea—Lisinopril—systemic scleroderma	0.000446	0.000513	CcSEcCtD
Risedronate—Anaemia—Prednisone—systemic scleroderma	0.000439	0.000504	CcSEcCtD
Risedronate—Angioedema—Prednisone—systemic scleroderma	0.000434	0.000498	CcSEcCtD
Risedronate—Dizziness—Lisinopril—systemic scleroderma	0.000431	0.000495	CcSEcCtD
Risedronate—Nausea—Mycophenolic acid—systemic scleroderma	0.00043	0.000494	CcSEcCtD
Risedronate—Vertigo—Prednisone—systemic scleroderma	0.000427	0.00049	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—systemic scleroderma	0.000426	0.000489	CcSEcCtD
Risedronate—Syncope—Prednisone—systemic scleroderma	0.000426	0.000489	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—systemic scleroderma	0.000425	0.000488	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000423	0.000486	CcSEcCtD
Risedronate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000484	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—systemic scleroderma	0.000417	0.000479	CcSEcCtD
Risedronate—Vomiting—Lisinopril—systemic scleroderma	0.000415	0.000476	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—systemic scleroderma	0.000413	0.000475	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—systemic scleroderma	0.000412	0.000473	CcSEcCtD
Risedronate—Rash—Lisinopril—systemic scleroderma	0.000411	0.000472	CcSEcCtD
Risedronate—Dermatitis—Lisinopril—systemic scleroderma	0.000411	0.000472	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000411	0.000472	CcSEcCtD
Risedronate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000471	CcSEcCtD
Risedronate—Hypertension—Prednisone—systemic scleroderma	0.00041	0.000471	CcSEcCtD
Risedronate—Headache—Lisinopril—systemic scleroderma	0.000409	0.000469	CcSEcCtD
Risedronate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000404	0.000464	CcSEcCtD
Risedronate—Myalgia—Prednisone—systemic scleroderma	0.000404	0.000464	CcSEcCtD
Risedronate—Arthralgia—Prednisone—systemic scleroderma	0.000404	0.000464	CcSEcCtD
Risedronate—Anxiety—Prednisone—systemic scleroderma	0.000403	0.000463	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000401	0.000461	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—systemic scleroderma	0.000399	0.000459	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—systemic scleroderma	0.000397	0.000456	CcSEcCtD
Risedronate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000449	CcSEcCtD
Risedronate—Nausea—Lisinopril—systemic scleroderma	0.000387	0.000445	CcSEcCtD
Risedronate—Infection—Prednisone—systemic scleroderma	0.000385	0.000442	CcSEcCtD
Risedronate—Back pain—Methotrexate—systemic scleroderma	0.000384	0.000441	CcSEcCtD
Risedronate—Shock—Prednisone—systemic scleroderma	0.000381	0.000438	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—systemic scleroderma	0.00038	0.000436	CcSEcCtD
Risedronate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000434	CcSEcCtD
Risedronate—Skin disorder—Prednisone—systemic scleroderma	0.000376	0.000432	CcSEcCtD
Risedronate—Anaemia—Methotrexate—systemic scleroderma	0.000367	0.000421	CcSEcCtD
Risedronate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000363	0.000417	CcSEcCtD
Risedronate—Rash—Mycophenolate mofetil—systemic scleroderma	0.00036	0.000414	CcSEcCtD
Risedronate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00036	0.000413	CcSEcCtD
Risedronate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000411	CcSEcCtD
Risedronate—Vertigo—Methotrexate—systemic scleroderma	0.000356	0.000409	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000353	0.000405	CcSEcCtD
Risedronate—Insomnia—Prednisone—systemic scleroderma	0.00035	0.000402	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—systemic scleroderma	0.000348	0.0004	CcSEcCtD
Risedronate—Cough—Methotrexate—systemic scleroderma	0.000346	0.000398	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—systemic scleroderma	0.000341	0.000392	CcSEcCtD
Risedronate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00039	CcSEcCtD
Risedronate—Myalgia—Methotrexate—systemic scleroderma	0.000338	0.000388	CcSEcCtD
Risedronate—Chest pain—Methotrexate—systemic scleroderma	0.000338	0.000388	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—systemic scleroderma	0.000338	0.000388	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000335	0.000385	CcSEcCtD
Risedronate—Fatigue—Prednisone—systemic scleroderma	0.000334	0.000384	CcSEcCtD
Risedronate—Constipation—Prednisone—systemic scleroderma	0.000331	0.00038	CcSEcCtD
Risedronate—Infection—Methotrexate—systemic scleroderma	0.000322	0.000369	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000318	0.000365	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000317	0.000364	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—systemic scleroderma	0.000315	0.000361	CcSEcCtD
Risedronate—Urticaria—Prednisone—systemic scleroderma	0.000308	0.000353	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—systemic scleroderma	0.000306	0.000352	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—systemic scleroderma	0.000306	0.000352	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000295	0.000339	CcSEcCtD
Risedronate—Insomnia—Methotrexate—systemic scleroderma	0.000293	0.000336	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—systemic scleroderma	0.000291	0.000334	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—systemic scleroderma	0.000289	0.000332	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—systemic scleroderma	0.000285	0.000328	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—systemic scleroderma	0.000285	0.000327	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00028	0.000321	CcSEcCtD
Risedronate—Fatigue—Methotrexate—systemic scleroderma	0.000279	0.000321	CcSEcCtD
Risedronate—Asthenia—Prednisone—systemic scleroderma	0.000278	0.000319	CcSEcCtD
Risedronate—Pain—Methotrexate—systemic scleroderma	0.000277	0.000318	CcSEcCtD
Risedronate—Pruritus—Prednisone—systemic scleroderma	0.000274	0.000315	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—systemic scleroderma	0.000265	0.000304	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000265	0.000304	CcSEcCtD
Risedronate—Urticaria—Methotrexate—systemic scleroderma	0.000257	0.000295	CcSEcCtD
Risedronate—Dizziness—Prednisone—systemic scleroderma	0.000256	0.000294	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—systemic scleroderma	0.000256	0.000294	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—systemic scleroderma	0.000256	0.000294	CcSEcCtD
Risedronate—Vomiting—Prednisone—systemic scleroderma	0.000246	0.000283	CcSEcCtD
Risedronate—Rash—Prednisone—systemic scleroderma	0.000244	0.000281	CcSEcCtD
Risedronate—Dermatitis—Prednisone—systemic scleroderma	0.000244	0.00028	CcSEcCtD
Risedronate—Headache—Prednisone—systemic scleroderma	0.000243	0.000279	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000239	0.000274	CcSEcCtD
Risedronate—Asthenia—Methotrexate—systemic scleroderma	0.000232	0.000267	CcSEcCtD
Risedronate—Nausea—Prednisone—systemic scleroderma	0.00023	0.000264	CcSEcCtD
Risedronate—Pruritus—Methotrexate—systemic scleroderma	0.000229	0.000263	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—systemic scleroderma	0.000222	0.000254	CcSEcCtD
Risedronate—Dizziness—Methotrexate—systemic scleroderma	0.000214	0.000246	CcSEcCtD
Risedronate—Vomiting—Methotrexate—systemic scleroderma	0.000206	0.000236	CcSEcCtD
Risedronate—Rash—Methotrexate—systemic scleroderma	0.000204	0.000234	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—systemic scleroderma	0.000204	0.000234	CcSEcCtD
Risedronate—Headache—Methotrexate—systemic scleroderma	0.000203	0.000233	CcSEcCtD
Risedronate—Nausea—Methotrexate—systemic scleroderma	0.000192	0.000221	CcSEcCtD
